Keywords: Bayer, Eylea, macular edema following CRVO, Japan, Santen Pharma, Regeneron

Bayer files for Japanese approval of Eylea for macular edema following CRVO

Article | 07 January 2013

Print This

German drug major Bayer(BAYN: DE) says its subsidiary Bayer Yakuhin has applied to the Japanese Ministry of Health, Labor ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in